Staying on Top of Medical Necessity and Marketer Compliance
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas.
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas.
Most healthcare-related enforcement actions from July and August involved urine drug tests and genetic testing.
The OIG’s new Fraud Alert can help labs and other providers steer clear of potentially suspect arrangements with telemedicine companies.
The DOJ recently charged 21 defendants across the US for allegedly carrying out COVID-19 scams worth just under $150 million.